The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
Jing Guo(Zhejiang University), Chengyu Jiang(Wenzhou University), Huandi Zhou, Hainv Gao, George F. Gao(Chinese Center For Disease Control and Prevention), Kunkai Su(Jinan Stomatological Hospital), Yan Zhao(Tarim University), Jun Xu(Shanxi Medical University), Hongyan Diao(National Center for Infectious Diseases), Zhen Zou(Chongqing Institute of Green and Intelligent Technology), Xuetao Cao(Second Military Medical University), Jingdong Zhu, Min Zhao(Chinese Academy of Sciences), Li Shao, Yida Yang, Jiezuan Yang, Lanjuan Li(First Affiliated Hospital Zhejiang University), Haixia Xiao, Changjun Bao(Jiangsu Provincial Center for Disease Control and Prevention), Shufa Zheng, Hongcui Cao(National Clinical Research Center for Digestive Diseases), Shuguang Tan, Li Wang(West China Hospital of Sichuan University), Song Liu(Qingdao University), Jun Liu(Jinan University), Xiaoli Liu(Qingdao Agricultural University), Wei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu Chen(First Affiliated Hospital Zhejiang University), Qiang Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianwei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianmin Zhang(Roswell Park Comprehensive Cancer Center), Bin Cao(Fujian University of Traditional Chinese Medicine), Ying Wu(Zhejiang Chinese Medical University), Hui Li(Capital Medical University), Xiaoqing Xu(Harbin Medical University), Nanshan Zhong(State Key Laboratory of Respiratory Disease), Shigui Yang, Weifeng Liang, Chunmei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jingcao Pan, Dangsheng Li, Fengming Huang, Mei Zeng(Affiliated Hospital of Southwest Medical University)
Cited by 110
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k